Hct 089pharm (Hydrochlorothiazide)

Hydrochlorothiazide in Hct 089pharm is indicated for the oral treatment of several conditions where reduction of excess fluid or blood pressure is required and related complications.

• Hypertension (high blood pressure) management in adults.
• Edema associated with congestive heart failure.
• Fluid retention due to liver cirrhosis.
• Edema secondary to renal disease.
• Adjunct therapy for nephrolithiasis prevention.
• Prevention of calcium‑containing kidney stone formation.

Hydrochlorothiazide may cause a range of side effects, most of which are mild and reversible, while rare events can be serious and require medical attention.

Common

• Increased frequency of urination that may lead to mild dehydration if fluid intake is not adjusted.
• Low serum potassium (hypokalemia) or sodium (hyponatremia) detected in routine blood tests.
• Dizziness, light‑headedness, or faintness, especially when moving to a standing position.

Serious

• Severe electrolyte disturbances such as marked hyponatremia, hypokalemia, or metabolic alkalosis that require medical monitoring.
• Acute kidney injury or a noticeable decline in renal function, particularly in patients with pre‑existing kidney disease.
• Allergic reactions ranging from skin rash and itching to angioedema or anaphylaxis.

Before initiating therapy with Hct 089pharm, healthcare providers should evaluate patient history, existing medical conditions, and concomitant medications to minimize risks and ensure safe use in specific populations.

• Assess renal function; avoid use in severe impairment.
• Monitor electrolytes, especially potassium and sodium, during treatment.
• Use cautiously in patients with diabetes or gout.
• Review antihypertensive regimen to prevent excessive blood pressure lowering.
• Consider pregnancy status; safety data are limited.
• Evaluate for sulfonamide allergy, as hydrochlorothiazide is a sulfonamide derivative.

Hct 089pharm can interact with other medicines, altering its diuretic effect or increasing the risk of adverse events; recognizing these interactions helps guide safe prescribing and monitoring for patients throughout therapy.

Avoid

• Concurrent use with other thiazide or loop diuretics.
• Combination with lithium, which may increase lithium toxicity.
• Co‑administration with NSAIDs that can reduce diuretic efficacy.

Use with caution

• ACE inhibitors or ARBs, which may enhance potassium loss.
• Antidiabetic agents, as blood glucose may rise.
• Corticosteroids, which can increase fluid retention.
• Anticoagulants, due to potential changes in plasma volume.